| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.83B | 24.93B | 24.42B | 24.43B | 21.68B | 20.64B |
| Gross Profit | 11.87B | 4.88B | 9.16B | 4.00B | 2.68B | 2.14B |
| EBITDA | 10.54B | 9.87B | 9.94B | 7.85B | 6.73B | 6.27B |
| Net Income | 2.95B | 2.70B | 2.51B | 2.26B | 1.81B | -88.00M |
Balance Sheet | ||||||
| Total Assets | 141.95B | 141.61B | 133.66B | 125.70B | 118.64B | 103.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.49B | 713.00M | 940.00M | 635.00M | 734.00M | 291.00M |
| Total Debt | 62.94B | 61.34B | 58.34B | 57.73B | 53.54B | 46.17B |
| Total Liabilities | 108.45B | 108.82B | 103.26B | 100.41B | 95.57B | 82.10B |
| Stockholders Equity | 33.25B | 32.54B | 30.15B | 25.04B | 22.82B | 20.97B |
Cash Flow | ||||||
| Free Cash Flow | -4.21B | -3.07B | -2.33B | -4.97B | -5.86B | -5.43B |
| Operating Cash Flow | 8.30B | 8.72B | 8.04B | 4.75B | 3.72B | 2.26B |
| Investing Cash Flow | -12.35B | -12.32B | -11.38B | -9.16B | -10.21B | -6.91B |
| Financing Cash Flow | 3.14B | 3.36B | 3.62B | 4.40B | 7.13B | 4.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $73.20B | 25.70 | 12.06% | 3.25% | 10.46% | 19.64% | |
68 Neutral | $99.18B | 19.23 | 9.69% | 3.61% | 6.19% | 11.06% | |
66 Neutral | $108.21B | 20.00 | 12.28% | 3.40% | 8.33% | -6.26% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $30.52B | 30.64 | 12.16% | 3.45% | 22.33% | -17.75% | |
64 Neutral | $27.06B | 18.07 | 8.38% | 3.94% | 11.30% | -1.99% | |
62 Neutral | $35.70B | 10.91 | 9.16% | 0.66% | 5.26% | 18.73% |